Aging‐related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's disease

Documenti analoghi

• Biofluid‐based biomarkers to predict onset of Alzheimer's disease neuropathology
  di: Henrik Zetterberg, et al.
  Pubblicazione: (2025)
• Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
  di: Sofia Toniolo, et al.
  Pubblicazione: (2024)
• The Alzheimer's Disease Diagnosis and Plasma Phospho‐Tau217 (ADAPT) study stage 1: Validating clinical cut‐points against CSF and amyloid PET
  di: Ashvini Keshavan, et al.
  Pubblicazione: (2026)
• Pulse pressure is associated with Alzheimer's disease pathology and cognitive decline
  di: Joon Hyung Jung, et al.
  Pubblicazione: (2025)
• Evaluating blood‐based biomarkers for Alzheimer's disease diagnosis across ethnic groups: a systematic review
  di: Natalia Chemas, et al.
  Pubblicazione: (2025)